drugset / Trial / NCT00019110
Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
Treatment
Summary
RATIONALE: Vaccines made from certain human papillomaviruses may be able to help the body to kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of human papillomavirus vaccine therapy in treating patients who have advanced or recurrent cancer of the cervix, vagina, penis, anus, esophagus, or head and neck.
Timeline
- Start
- 1995-11
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human papillomavirus 16 E7 peptide | Peptide | — | Intravenous |
| Subject | synthetic human papillomavirus 16 E6 peptide | Peptide | — | Intravenous |